SpeeDx Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 113

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $26M

  • Investors
  • 12

SpeeDx General Information

Description

Developer of a molecular diagnostics test portfolio designed to provide innovative multiplex systems for clinical diagnostics. The company's test portfolio uses real-time polymerase chain reaction technology for multiplex detection and priming strategies, enabling physicians to test infectious disease and antibiotic resistance.

Contact Information

Website
www.plexpcr.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • National Innovation Centre, 4 Cornwallis Street
  • Suite 102
  • Eveleigh, New South Wales 2015
  • Australia
+61 (02) 0000 0000

SpeeDx Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SpeeDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 28-Feb-2023 $26M 000.00 Completed Generating Revenue
12. Secondary Transaction - Private 000.00 Completed Generating Revenue
11. Grant 10-May-2021 00.00 000.00 Completed Generating Revenue
10. Later Stage VC (Series B) 11-Feb-2020 000.00 000.00 000.00 Completed Generating Revenue
9. Later Stage VC 05-Aug-2019 0000 0000 Completed Generating Revenue
8. Later Stage VC (Series A) 23-Apr-2019 000 000 Completed Generating Revenue
7. Later Stage VC 01-Jan-2018 Completed Generating Revenue
6. Grant 04-Sep-2017 00.000 Completed Generating Revenue
5. Grant 01-Aug-2016 $753K Completed Generating Revenue
4. Grant 01-Jul-2016 Completed Generating Revenue
To view SpeeDx’s complete valuation and funding history, request access »

SpeeDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
PREFERRED SERIES B 0,000,000 00.00 00.00 00 00.00 00.000
PREFERRED SERIES A 0,000,000 00.00 00.00 00 00.00 00.000
To view SpeeDx’s complete cap table history, request access »

SpeeDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular diagnostics test portfolio designed to provide innovative multiplex systems for clinical diagno
Diagnostic Equipment
Eveleigh, Australia
113 As of 2023
000.00
0000000000 0 000.00

000000

boris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
0000000000 000000000
Cincinnati, OH
000 As of 0000
00.000 0000-00-00
000000&0

000000

t enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
0000000000 000000000
San Diego, CA
0000 As of 0000
00.000
0000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SpeeDx Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Meridian Bioscience Private Equity-Backed Cincinnati, OH 000 000000&0
Illumina Formerly VC-backed San Diego, CA 0000 00.000 0000 00.000
AusDiagnostics Private Equity-Backed Mascot, Australia 00 000000000000
Luminex Corporate Backed or Acquired Austin, TX 0000 000.00 000000&0 000.00
Diagnostic Technology Corporation Belrose, Australia
You’re viewing 5 of 7 competitors. Get the full list »

SpeeDx Executive Team (6)

Name Title Board Seat Contact Info
Colin Denver Chief Executive Officer
Bhavin Raval Chief Financial Officer
Elisa Mokany Ph.D Co-Founder & Chief Technology Officer
Alison Todd Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 4 of 6 executive team members. Get the full list »

SpeeDx Board Members (10)

Name Representing Role Since
Bianca Ogden Ph.D Platinum Asset Management Board Member 000 0000
Ingo Chakravarty Self Board Member 000 0000
Jonathan Clark Self Chairman 000 0000
Lily Li Self Board Member 000 0000
Vicki DiFrancesco Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

SpeeDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SpeeDx Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tenmile Venture Capital Minority 000 0000 000000 0
CARB-X University 000 0000 000000 0
Illumina Ventures Corporate Venture Capital Minority 000 0000 000000 0
Platinum Asset Management Asset Manager Minority 000 0000 000000 0
Northpond Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

SpeeDx FAQs

  • When was SpeeDx founded?

    SpeeDx was founded in 2009.

  • Who is the founder of SpeeDx?

    Elisa Mokany Ph.D and Alison Todd Ph.D are the founders of SpeeDx.

  • Who is the CEO of SpeeDx?

    Colin Denver is the CEO of SpeeDx.

  • Where is SpeeDx headquartered?

    SpeeDx is headquartered in Eveleigh, Australia.

  • What is the size of SpeeDx?

    SpeeDx has 113 total employees.

  • What industry is SpeeDx in?

    SpeeDx’s primary industry is Diagnostic Equipment.

  • Is SpeeDx a private or public company?

    SpeeDx is a Private company.

  • What is SpeeDx’s current revenue?

    The current revenue for SpeeDx is 00000.

  • How much funding has SpeeDx raised over time?

    SpeeDx has raised $66.2M.

  • Who are SpeeDx’s investors?

    Tenmile, CARB-X, Illumina Ventures, Platinum Asset Management, and Northpond Ventures are 5 of 12 investors who have invested in SpeeDx.

  • Who are SpeeDx’s competitors?

    Meridian Bioscience, Illumina, AusDiagnostics, Luminex, and Diagnostic Technology are some of the 7 competitors of SpeeDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »